Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Infantile Spasms: Mom Saves Baby’s Life After Being Dismissed by Two Hospitals
    source: shutterstock.com

    Infantile Spasms: Mom Saves Baby’s Life After Being Dismissed by Two Hospitals

    Imagine the frustration of Faustina Cavero, unable to follow her maternal instincts that told her something was wrong with her baby. Doctors at two different hospitals disagreed with her and…

    Continue Reading Infantile Spasms: Mom Saves Baby’s Life After Being Dismissed by Two Hospitals
    Scientists Are Calling Monkey’s Two-Year Survival After a Pig Kidney Transplant “Unprecedented”
    source: pixabay.com

    Scientists Are Calling Monkey’s Two-Year Survival After a Pig Kidney Transplant “Unprecedented”

      The xenotransplant involved transplanting Yucatan miniature pig kidneys into macaque monkeys with 69 genetic modifications. One monkey survived for over two years, offering hope to the team of Harvard…

    Continue Reading Scientists Are Calling Monkey’s Two-Year Survival After a Pig Kidney Transplant “Unprecedented”

    Researchers Seek Reason for a Higher Survival Rate in Obese Patients with Pulmonary Arterial Hypertension (PAH)

    Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

    Continue Reading Researchers Seek Reason for a Higher Survival Rate in Obese Patients with Pulmonary Arterial Hypertension (PAH)
    Two CTCL Trails on Partial Hold After Patient Death
    source: shutterstock.com

    Two CTCL Trails on Partial Hold After Patient Death

      The two trials evaluating lacutamab, an investigational therapy developed to treat T-cell lymphomas, were put on partial hold by the FDA. The patient died of hemophagocytic lymphohistiocytosis, which is…

    Continue Reading Two CTCL Trails on Partial Hold After Patient Death
    Over 200 Rare Diseases to be Included in Genomics England Research Study
    source: pixabay.com

    Over 200 Rare Diseases to be Included in Genomics England Research Study

    Genomics is revolutionizing healthcare processes, offering the potential to enhance the lives of numerous individuals by enabling the early detection of treatable disorders and providing lifesaving therapies. Every year, thousands…

    Continue Reading Over 200 Rare Diseases to be Included in Genomics England Research Study
    Death of Muscular Dystrophy Patient Potentially Caused by Adeno-Associated Virus That Delivered Gene Therapy
    source: pixabay.com

    Death of Muscular Dystrophy Patient Potentially Caused by Adeno-Associated Virus That Delivered Gene Therapy

    For over four decades, the aspiration of gene therapy has been to develop novel therapies with the potential to enhance human health. Recombinant AAV (rAAV), a type of gene therapy,…

    Continue Reading Death of Muscular Dystrophy Patient Potentially Caused by Adeno-Associated Virus That Delivered Gene Therapy
    Ionis Pharmaceuticals Announces Positive Results in Familial Chylomicronemia Syndrome
    source: shutterstock.com

    Ionis Pharmaceuticals Announces Positive Results in Familial Chylomicronemia Syndrome

      This week Ionis Pharmaceuticals, Inc. issued a press release via PRNewswire announcing topline Phase 3 results for its Balance study of olezarsen. The study ( NCT04568434 ) enrolled people with…

    Continue Reading Ionis Pharmaceuticals Announces Positive Results in Familial Chylomicronemia Syndrome
    AI Can Predict Dementia Fifteen Years Prior to Symptoms Occurring
    source: pixabay.com

    AI Can Predict Dementia Fifteen Years Prior to Symptoms Occurring

    Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

    Continue Reading AI Can Predict Dementia Fifteen Years Prior to Symptoms Occurring
    Sufjan Stevens Shares Guillain-Barré Syndrome Diagnosis Prior to New Album Release
    source: shutterstock.com

    Sufjan Stevens Shares Guillain-Barré Syndrome Diagnosis Prior to New Album Release

      Indie songwriter and singer Sufjan Stevens recently posted on, Tumblr, his favorite media platform, that he has been diagnosed with Guillain-Barré syndrome (GBS). Sufjan is now in the hospital…

    Continue Reading Sufjan Stevens Shares Guillain-Barré Syndrome Diagnosis Prior to New Album Release
    Phase III Trial Results Show Significant Benefits in Patients with Metastatic Cervical Cancer
    pixabay.com

    Phase III Trial Results Show Significant Benefits in Patients with Metastatic Cervical Cancer

      Tivdak, Seagen, and Genmab’s antibody-drug conjugate exceeded expectations. The partners said that a Data Monitoring Committee, independent of either company, noted that Tivdak’s overall survival rating met and even…

    Continue Reading Phase III Trial Results Show Significant Benefits in Patients with Metastatic Cervical Cancer
    ICYMI: Alecensa Exhibited Unprecedented Results for Patients with Early-Stage Lung Cancer
    source: pixabay.com

    ICYMI: Alecensa Exhibited Unprecedented Results for Patients with Early-Stage Lung Cancer

    Over 50% of non-small cell lung cancer patients (NSCLC) will experience a recurrence after surgery. The cancer recurs even after adjuvant chemotherapy after major surgery. ALINA’s data show that Alecensa…

    Continue Reading ICYMI: Alecensa Exhibited Unprecedented Results for Patients with Early-Stage Lung Cancer